UK markets closed

Concord Medical Services Holdings Limited (CCM)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.5701-0.0098 (-1.69%)
As of 03:26PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.5799
Open0.5002
Bid0.5501 x 1100
Ask0.7301 x 800
Day's range0.5701 - 0.5701
52-week range0.3800 - 1.6000
Volume253
Avg. volume10,246
Market cap24.752M
Beta (5Y monthly)-0.17
PE ratio (TTM)N/A
EPS (TTM)-0.9400
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date23 Dec 2015
1y target estN/A
  • Simply Wall St.

    Concord Medical Services Holdings Full Year 2023 Earnings: CN¥6.81 loss per share (vs CN¥11.21 loss in FY 2022)

    Concord Medical Services Holdings ( NYSE:CCM ) Full Year 2023 Results Key Financial Results Revenue: CN¥537.4m (up 14...

  • PR Newswire

    Concord Medical Files 2023 Annual Report on Form 20-F

    Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on

  • PR Newswire

    Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price

    Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated February 12, 2024, notifying the Company that it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs") and that the applicable cure perio